AdaptHealth (AHCO) PT Lowered to $18 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections, more earnings
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts AHCO Hot Sheet
Price: $6.00 +3.27%
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 21 | New: 16
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 21 | New: 16
Join SI Premium – FREE
UBS analyst Kevin Caliendo lowered the price target on AdaptHealth (NASDAQ: AHCO) to $18.00 (from $25.00) while maintaining a Buy rating.
You May Also Be Interested In
- Bright Minds Biosciences Inc. (DRUG) PT Lowered to $107 at Baird amid partial clinical hold
- Teladoc (TDOC) PT Raised to $11 at Piper Sandler
- Hartford Financial Services (HIG) PT Lowered to $136 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
